Cargando…

Endorectal power Doppler/grayscale ultrasound-guided biopsies vs. multiparametric MRI/ultrasound fusion-guided biopsies in males with high risk of prostate cancer: A prospective cohort study

Multiparametric MRI fusion with transrectal ultrasound (mpMRI/TRUS)-guided biopsy has the sensitivity of mpMRI with the practicality of TRUS, but males with no cancerous lesion(s) detected on mpMRI have a considerable remaining risk of cancer. Endorectal power Doppler ultrasound improves the sensiti...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Zhizhong, Yuan, Zhifan, Liang, Limei, Xie, Xinx In, Yuan, Jianjun, He, Wenxu, Chen, Junjun, Kuang, Yongpei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878876/
https://www.ncbi.nlm.nih.gov/pubmed/31807154
http://dx.doi.org/10.3892/etm.2019.8151
_version_ 1783473527253368832
author He, Zhizhong
Yuan, Zhifan
Liang, Limei
Xie, Xinx In
Yuan, Jianjun
He, Wenxu
Chen, Junjun
Kuang, Yongpei
author_facet He, Zhizhong
Yuan, Zhifan
Liang, Limei
Xie, Xinx In
Yuan, Jianjun
He, Wenxu
Chen, Junjun
Kuang, Yongpei
author_sort He, Zhizhong
collection PubMed
description Multiparametric MRI fusion with transrectal ultrasound (mpMRI/TRUS)-guided biopsy has the sensitivity of mpMRI with the practicality of TRUS, but males with no cancerous lesion(s) detected on mpMRI have a considerable remaining risk of cancer. Endorectal power Doppler ultrasound improves the sensitivity of grayscale ultrasound-guided biopsies. The objective of the present study was to evaluate the beneficial effect of endorectal power Doppler/grayscale ultrasound-guided biopsy over that of mpMRI/TRUS-guided biopsy for decision-making regarding prostatectomy in males with a high risk of prostate cancer. Data regarding endorectal power Doppler/grayscale ultrasound-guided biopsies and mpMRI/TRUS-guided biopsies of 1,094 males with elevated specific prostate antigen, were included. Radical prostatectomy was performed in males aged <70 years with Gleason scores ≥3+4 in any one of the biopsy reports. The histopathological data of the surgical specimen of 776 males were included in the analysis. Compared to the histopathology of the surgical specimen, endorectal power Doppler/grayscale ultrasound-guided biopsies had a lower sensitivity (0.930 vs. 1.000; P<0.0001) but mpMRI/TRUS-guided biopsies had the same sensitivity (0.990 vs. 1.000; P=0.02). The accuracy of mpMRI/TRUS-guided biopsies was higher than that of endorectal power Doppler/grayscale ultrasound-guided biopsies (0.944 vs. 0.783). On mpMRI, lesions of 105 subjects (10%) with a Likert scale score of <3 were identified. Among them, 14 subjects (2%) had Gleason scores of ≥3+4 as determined by endorectal power Doppler/grayscale ultrasound-guided biopsies. In addition, 20 (2%) false-positive lesions compared to the histopathological analysis of the surgical specimen were identified from mpMRI/TRUS-guided biopsies. In conclusion, mpMRI/TRUS-guided biopsy was indicated to have a moderate performance and endorectal power Doppler/grayscale ultrasound-guided biopsy had a scant performance for decision-making regarding prostatectomy.
format Online
Article
Text
id pubmed-6878876
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-68788762019-12-05 Endorectal power Doppler/grayscale ultrasound-guided biopsies vs. multiparametric MRI/ultrasound fusion-guided biopsies in males with high risk of prostate cancer: A prospective cohort study He, Zhizhong Yuan, Zhifan Liang, Limei Xie, Xinx In Yuan, Jianjun He, Wenxu Chen, Junjun Kuang, Yongpei Exp Ther Med Articles Multiparametric MRI fusion with transrectal ultrasound (mpMRI/TRUS)-guided biopsy has the sensitivity of mpMRI with the practicality of TRUS, but males with no cancerous lesion(s) detected on mpMRI have a considerable remaining risk of cancer. Endorectal power Doppler ultrasound improves the sensitivity of grayscale ultrasound-guided biopsies. The objective of the present study was to evaluate the beneficial effect of endorectal power Doppler/grayscale ultrasound-guided biopsy over that of mpMRI/TRUS-guided biopsy for decision-making regarding prostatectomy in males with a high risk of prostate cancer. Data regarding endorectal power Doppler/grayscale ultrasound-guided biopsies and mpMRI/TRUS-guided biopsies of 1,094 males with elevated specific prostate antigen, were included. Radical prostatectomy was performed in males aged <70 years with Gleason scores ≥3+4 in any one of the biopsy reports. The histopathological data of the surgical specimen of 776 males were included in the analysis. Compared to the histopathology of the surgical specimen, endorectal power Doppler/grayscale ultrasound-guided biopsies had a lower sensitivity (0.930 vs. 1.000; P<0.0001) but mpMRI/TRUS-guided biopsies had the same sensitivity (0.990 vs. 1.000; P=0.02). The accuracy of mpMRI/TRUS-guided biopsies was higher than that of endorectal power Doppler/grayscale ultrasound-guided biopsies (0.944 vs. 0.783). On mpMRI, lesions of 105 subjects (10%) with a Likert scale score of <3 were identified. Among them, 14 subjects (2%) had Gleason scores of ≥3+4 as determined by endorectal power Doppler/grayscale ultrasound-guided biopsies. In addition, 20 (2%) false-positive lesions compared to the histopathological analysis of the surgical specimen were identified from mpMRI/TRUS-guided biopsies. In conclusion, mpMRI/TRUS-guided biopsy was indicated to have a moderate performance and endorectal power Doppler/grayscale ultrasound-guided biopsy had a scant performance for decision-making regarding prostatectomy. D.A. Spandidos 2019-12 2019-10-31 /pmc/articles/PMC6878876/ /pubmed/31807154 http://dx.doi.org/10.3892/etm.2019.8151 Text en Copyright: © He et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
He, Zhizhong
Yuan, Zhifan
Liang, Limei
Xie, Xinx In
Yuan, Jianjun
He, Wenxu
Chen, Junjun
Kuang, Yongpei
Endorectal power Doppler/grayscale ultrasound-guided biopsies vs. multiparametric MRI/ultrasound fusion-guided biopsies in males with high risk of prostate cancer: A prospective cohort study
title Endorectal power Doppler/grayscale ultrasound-guided biopsies vs. multiparametric MRI/ultrasound fusion-guided biopsies in males with high risk of prostate cancer: A prospective cohort study
title_full Endorectal power Doppler/grayscale ultrasound-guided biopsies vs. multiparametric MRI/ultrasound fusion-guided biopsies in males with high risk of prostate cancer: A prospective cohort study
title_fullStr Endorectal power Doppler/grayscale ultrasound-guided biopsies vs. multiparametric MRI/ultrasound fusion-guided biopsies in males with high risk of prostate cancer: A prospective cohort study
title_full_unstemmed Endorectal power Doppler/grayscale ultrasound-guided biopsies vs. multiparametric MRI/ultrasound fusion-guided biopsies in males with high risk of prostate cancer: A prospective cohort study
title_short Endorectal power Doppler/grayscale ultrasound-guided biopsies vs. multiparametric MRI/ultrasound fusion-guided biopsies in males with high risk of prostate cancer: A prospective cohort study
title_sort endorectal power doppler/grayscale ultrasound-guided biopsies vs. multiparametric mri/ultrasound fusion-guided biopsies in males with high risk of prostate cancer: a prospective cohort study
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878876/
https://www.ncbi.nlm.nih.gov/pubmed/31807154
http://dx.doi.org/10.3892/etm.2019.8151
work_keys_str_mv AT hezhizhong endorectalpowerdopplergrayscaleultrasoundguidedbiopsiesvsmultiparametricmriultrasoundfusionguidedbiopsiesinmaleswithhighriskofprostatecanceraprospectivecohortstudy
AT yuanzhifan endorectalpowerdopplergrayscaleultrasoundguidedbiopsiesvsmultiparametricmriultrasoundfusionguidedbiopsiesinmaleswithhighriskofprostatecanceraprospectivecohortstudy
AT lianglimei endorectalpowerdopplergrayscaleultrasoundguidedbiopsiesvsmultiparametricmriultrasoundfusionguidedbiopsiesinmaleswithhighriskofprostatecanceraprospectivecohortstudy
AT xiexinxin endorectalpowerdopplergrayscaleultrasoundguidedbiopsiesvsmultiparametricmriultrasoundfusionguidedbiopsiesinmaleswithhighriskofprostatecanceraprospectivecohortstudy
AT yuanjianjun endorectalpowerdopplergrayscaleultrasoundguidedbiopsiesvsmultiparametricmriultrasoundfusionguidedbiopsiesinmaleswithhighriskofprostatecanceraprospectivecohortstudy
AT hewenxu endorectalpowerdopplergrayscaleultrasoundguidedbiopsiesvsmultiparametricmriultrasoundfusionguidedbiopsiesinmaleswithhighriskofprostatecanceraprospectivecohortstudy
AT chenjunjun endorectalpowerdopplergrayscaleultrasoundguidedbiopsiesvsmultiparametricmriultrasoundfusionguidedbiopsiesinmaleswithhighriskofprostatecanceraprospectivecohortstudy
AT kuangyongpei endorectalpowerdopplergrayscaleultrasoundguidedbiopsiesvsmultiparametricmriultrasoundfusionguidedbiopsiesinmaleswithhighriskofprostatecanceraprospectivecohortstudy